Public disclosures

Taylor Andrew Lawrence

Company insiders · Chief Financial Officer · Orchestra BioMed Holdings, Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-20.Following & alerts
Reported transaction lines
2
Buy lines
1
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-112

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Taylor Andrew Lawrence

Chief Financial Officer · Orchestra BioMed Holdings, Inc.

OBIO

Orchestra BioMed Holdings, Inc.

Other transaction
Filing details

SEC transaction code F

Common Stock, par value $0.0001 per share · Direct ownership · Reported balance after transaction: 587913 · Securities delivered or withheld for tax or exercise payment · Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

2026-11-202026-11-20

3,076 shares/units

SEC 4
Taylor Andrew Lawrence

Chief Financial Officer · Orchestra BioMed Holdings, Inc.

OBIO

Orchestra BioMed Holdings, Inc.

Buy
Filing details

SEC transaction code P

Common Stock, par value $0.0001 per share · Direct ownership · Reported balance after transaction: 590989 · SEC code covers open-market or private transactions · These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share.

2026-11-092026-11-09

≈ $5,000.00

1,000 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement